Your browser doesn't support javascript.
loading
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study.
Zhang, Dongming; Liu, Xiaoyan; Shen, Fangfang; Zhao, Dahai; Shi, Yuequan; Zhang, Haoran; Liu, Jia; Gao, Xiaoxing; Chen, Minjiang; Zhao, Jing; Zhong, Wei; Gao, Junzhen; He, Min; Liu, Yonggang; Yang, Xiaoling; Qin, Jianwen; Tang, Yuling; Mu, Xinlin; Gu, Yangchun; Zhang, Shucai; Chen, Xueqin; Pang, Li; Meng, Qingwei; Guo, Ye; Zhang, Yuhui; Li, Wei; Xing, Puyuan; Cheng, Yuan; Xin, Tao; Li, Qingxia; Li, Yu; Chen, Jun; Gao, Feng; Jin, Bo; Rossi, Antonio; Adachi, Hiroyuki; Guerrera, Francesco; Husain, Hatim; Xu, Yan; Wang, Mengzhao.
Afiliação
  • Zhang D; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Liu X; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Shen F; Department of Respiratory Medicine, Shanxi Province Cancer Hospital, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Zhao D; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Anhui Medical University, Hefei, China.
  • Shi Y; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Zhang H; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Liu J; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Gao X; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Chen M; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Zhao J; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Zhong W; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Gao J; Department of Respiratory and Critical Care Medicine, The Affiliated hospital of Inner Mongolia Medical University, Inner Mongolia, China.
  • He M; Department of Oncology, Inner Mongolia Autonomous Region People's Hospital, Inner Mongolia, China.
  • Liu Y; Department of Thoracic Oncology, Baotou Cancer Hospital, Inner Mongolia, China.
  • Yang X; Department of Thoracic Oncology, Shanxi Bethune Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
  • Qin J; Department of Respiratory and Critical Medicine, Tianjin Chest Hospital, Tianjin, China.
  • Tang Y; Respiratory Medical Center, First Hospital of Changsha, Changsha, China.
  • Mu X; Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, China.
  • Gu Y; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.
  • Zhang S; Department of Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Chen X; Department of Thoracic Oncology, Hangzhou Cancer Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Pang L; Department of Respiratory and Critical Care, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Meng Q; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Guo Y; Cancer Center, The First Hospital of Jilin University, Changchun, China.
  • Zhang Y; Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
  • Li W; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
  • Xing P; Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Cheng Y; Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China.
  • Xin T; Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Li Q; Department of Oncology, Hebei General Hospital, Shijiazhuang, China.
  • Li Y; Department of Respiratory Medicine, Qilu Hospital of Shandong University, Jinan, China.
  • Chen J; Department of Lung Cancer Surgery, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Gao F; Department of Oncology, Beidahuang Industry Group General Hospital, Harbin, China.
  • Jin B; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
  • Rossi A; Oncology Center of Excellence, Therapeutic Science & Strategy Unit, IQVIA, Milan, Italy.
  • Adachi H; Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
  • Guerrera F; Department of Surgical Science, University of Torino, Torino, Italy.
  • Husain H; Department of Thoracic Surgery, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
  • Xu Y; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
  • Wang M; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Transl Lung Cancer Res ; 12(11): 2229-2244, 2023 Nov 30.
Article em En | MEDLINE | ID: mdl-38090527
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transl Lung Cancer Res Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transl Lung Cancer Res Ano de publicação: 2023 Tipo de documento: Article